Literature DB >> 17581932

Nosocomial outbreak due to extended-spectrum-beta-lactamase- producing Enterobacter cloacae in a cardiothoracic intensive care unit.

Adriana Manzur1, Fe Tubau, Miquel Pujol, Laura Calatayud, Maria Angeles Dominguez, Carmen Peña, Mercedes Sora, Francesc Gudiol, Javier Ariza.   

Abstract

Enterobacter cloacae has been associated with several outbreaks, usually involving strains that overproduce chromosomal beta-lactamase or, uncommonly, strains expressing extended-spectrum beta-lactamases (ESBL). Only sporadic cases of ESBL-producing E. cloacae have been identified in our hospital in recent years. We describe the epidemiology and clinical and microbiological characteristics of an outbreak caused by ESBL-producing E. cloacae in a cardiothoracic intensive care unit (CT-ICU). Prospective surveillance of patients with infection or colonization by ESBL-producing E. cloacae among patients admitted to the CT-ICU was performed during the outbreak. Production of ESBL was determined by decreased susceptibility to expanded-spectrum cephalosporins and a positive double-disk test result. Clone relatedness was determined by pulsed-field gel electrophoresis (PFGE). From July to September 2005, seven patients in the CT-ICU with ESBL-producing E. cloacae were identified (four males; median age, 73 years; range, 45 to 76 years); six patients had cardiac surgery. Four patients developed infections; three had primary bacteremia, one had ventilator-associated pneumonia, and one had tracheobronchitis. ESBL-producing E. cloacae showed resistance to quinolones and aminoglycosides. PFGE revealed two patterns. Five isolates belonged to clone A; two carried a single ESBL (pI 8.2 and a positive PCR result for the SHV type), and three carried two ESBLs (pIs 8.1 and 8.2 and positive PCR results for the SHV and CTX-M-9 types). Isolates belonging to clone B carried a single ESBL (pI 5.4 and a positive PCR result for the TEM type). Review of antibiotic consumption showed increased use of cefepime and quinolones during June and July 2005. The outbreak was stopped by the implementation of barrier measures and cephalosporin restriction. ESBL production could be increasingly common in nosocomial pathogens other than Escherichia coli or Klebsiella pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581932      PMCID: PMC1951272          DOI: 10.1128/JCM.02546-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species.

Authors:  K Lee; Y Chong; H B Shin; Y A Kim; D Yong; J H Yum
Journal:  Clin Microbiol Infect       Date:  2001-02       Impact factor: 8.067

2.  Salmonella enterica serovar virchow with CTX-M-like beta-lactamase in Spain.

Authors:  E Simarro; F Navarro; J Ruiz; E Miró; J Gómez; B Mirelis
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.

Authors:  E Tzelepi; P Giakkoupi; D Sofianou; V Loukova; A Kemeroglou; A Tsakris
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.

Authors:  J M Bell; J D Turnidge; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

5.  Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000).

Authors:  Teresa M Coque; Antonio Oliver; José Claudio Pérez-Díaz; Fernando Baquero; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

6.  Outbreak of infections caused by Enterobacter cloacae producing the integron-associated beta-lactamase IBC-1 in a neonatal intensive care unit of a Greek hospital.

Authors:  Georgia Kartali; Eva Tzelepi; Spyros Pournaras; Constantina Kontopoulou; Fanourios Kontos; Danai Sofianou; Antonios N Maniatis; Athanassios Tsakris
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

7.  Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period.

Authors:  Rafael Cantón; Antonio Oliver; Teresa M Coque; María del Carmen Varela; José Claudio Pérez-Díaz; Fernando Baquero
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

8.  Two consecutive outbreaks of Acinetobacter baumanii 1-a in a burn Intensive Care Unit for adults.

Authors:  R Herruzo; J de la Cruz; M J Fernández-Aceñero; J Garcia-Caballero
Journal:  Burns       Date:  2004-08       Impact factor: 2.744

9.  Extended-spectrum beta-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals.

Authors:  E Tzelepi; Ch Magana; E Platsouka; D Sofianou; O Paniara; N J Legakis; A C Vatopoulos; L S Tzouvelekis
Journal:  Int J Antimicrob Agents       Date:  2003-03       Impact factor: 5.283

10.  Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp.

Authors:  K Lee; Y S Lim; D Yong; J H Yum; Y Chong
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

View more
  12 in total

1.  Gastrointestinal colonization with ESBL-producing Klebsiella in preterm babies--is vancomycin to blame?

Authors:  N Ofek-Shlomai; S Benenson; Z Ergaz; O Peleg; R Braunstein; B Bar-Oz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-04       Impact factor: 3.267

2.  Method for phenotypic detection of extended-spectrum beta-lactamases in enterobacter species in the routine clinical setting.

Authors:  James Cohen Stuart; Bram Diederen; Nashwan Al Naiemi; Ad Fluit; Niek Arents; Steven Thijsen; Bart Vlaminckx; Johan W Mouton; Maurine Leverstein-van Hall
Journal:  J Clin Microbiol       Date:  2011-05-11       Impact factor: 5.948

3.  Mortality factor 4 like 1 protein mediates epithelial cell death in a mouse model of pneumonia.

Authors:  Chunbin Zou; Jin Li; Sheng Xiong; Yan Chen; Qin Wu; Xiuying Li; Nathaniel M Weathington; SeungHye Han; Courtney Snavely; Bill B Chen; Rama K Mallampalli
Journal:  Sci Transl Med       Date:  2015-10-28       Impact factor: 17.956

4.  Emergence in Spain of a multidrug-resistant Enterobacter cloacae clinical isolate producing SFO-1 extended-spectrum beta-lactamase.

Authors:  Ana Fernández; María José Pereira; José Manuel Suárez; Margarita Poza; Mercedes Treviño; Pilar Villalón; Juan Antonio Sáez-Nieto; Benito José Regueiro; Rosa Villanueva; Germán Bou
Journal:  J Clin Microbiol       Date:  2011-01-12       Impact factor: 5.948

Review 5.  The continuing challenge of ESBLs.

Authors:  Federico Perez; Andrea Endimiani; Kristine M Hujer; Robert A Bonomo
Journal:  Curr Opin Pharmacol       Date:  2007-09-17       Impact factor: 5.547

6.  Phenotypic characterization of ESBL producing Enterobacter cloacae among children.

Authors:  Hafsa Amin; Aizza Zafar; Hasan Ejaz; Noor-Ul-Ain Jameel
Journal:  Pak J Med Sci       Date:  2013-01       Impact factor: 1.088

7.  Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study.

Authors:  Makiko Uemura; Osamu Imataki; Shumpei Uchida; Haruyuki Nakayama-Imaohji; Yukiko Ohue; Harumi Matsuka; Hatsune Mori; Hiroaki Dobashi; Tomomi Kuwahara; Norimitsu Kadowaki
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

8.  Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case-control study.

Authors:  Patrick N A Harris; Anna M Peri; Anita M Pelecanos; Carly M Hughes; David L Paterson; John K Ferguson
Journal:  Antimicrob Resist Infect Control       Date:  2017-01-21       Impact factor: 4.887

9.  Emergence of third-generation cephalosporin-resistant Enterobacteriacae in a Japanese critical care setting.

Authors:  Hideharu Hagiya; Tomoko Murase; Masato Suzuki; Fumio Otsuka; Keigo Shibayama
Journal:  Acute Med Surg       Date:  2014-07-10

10.  Persistence of related bla-IMP-4 metallo-beta-lactamase producing Enterobacteriaceae from clinical and environmental specimens within a burns unit in Australia - a six-year retrospective study.

Authors:  Grace Hy Leung; Timothy J Gray; Elaine Yl Cheong; Peter Haertsch; Thomas Gottlieb
Journal:  Antimicrob Resist Infect Control       Date:  2013-12-18       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.